Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
NPJ Vaccines
|
February 13, 2020
The promise of mRNA vaccines: a biotech and industrial perspective
Nicholas A C Jackson, Kent E Kester, Danilo Casimiro, et al.
Human Gene Therapy
|
January 29, 2002
Hexon gene switch strategy for the generation of chimeric recombinant adenovirus
Rima Youil, Timothy J Toner, Qin Su, et al.
F1000Research
|
March 24, 2018
Progress and challenges in TB vaccine development
Gerald Voss, Danilo Casimiro, Olivier Neyrolles, et al.
Human Vaccines & Immunotherapeutics
|
May 12, 2017
Functionally inactivated dominant viral antigens of human cytomegalovirus delivered in replication incompetent adenovirus type 6 vectors as vaccine candidates
Aimin Tang, Daniel C Freed, Fengsheng Li, et al.
Journal of Virology
|
April 12, 2012
The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes
Matthieu Perreau, Hugh C Welles, Celine Pellaton, et al.
The Journal of Infectious Diseases
|
July 29, 2010
AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein
Robert T Schooley, John Spritzler, Hongying Wang, et al.
Plos One
|
June 4, 2016
Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein
Zhifeng Chen, Lan Zhang, Aimin Tang, et al.
Vaccine: X
|
August 7, 2019
Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment
Brian K Meyer, Mark A F Kendall, Donna M Williams, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 25, 2003
Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates
Stefania Lamartina, Luisa Silvi, Giuseppe Roscilli, et al.
Vaccine
|
March 13, 2012
An optimized SIV DNA vaccine can serve as a boost for Ad5 and provide partial protection from a high-dose SIVmac251 challenge
Natalie A Hutnick, Devin J F Myles, Lauren Hirao, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
NPJ Vaccines
|
February 13, 2020
The promise of mRNA vaccines: a biotech and industrial perspective
Nicholas A C Jackson, Kent E Kester, Danilo Casimiro, et al.
Human Gene Therapy
|
January 29, 2002
Hexon gene switch strategy for the generation of chimeric recombinant adenovirus
Rima Youil, Timothy J Toner, Qin Su, et al.
F1000Research
|
March 24, 2018
Progress and challenges in TB vaccine development
Gerald Voss, Danilo Casimiro, Olivier Neyrolles, et al.
Human Vaccines & Immunotherapeutics
|
May 12, 2017
Functionally inactivated dominant viral antigens of human cytomegalovirus delivered in replication incompetent adenovirus type 6 vectors as vaccine candidates
Aimin Tang, Daniel C Freed, Fengsheng Li, et al.
Journal of Virology
|
April 12, 2012
The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes
Matthieu Perreau, Hugh C Welles, Celine Pellaton, et al.
The Journal of Infectious Diseases
|
July 29, 2010
AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein
Robert T Schooley, John Spritzler, Hongying Wang, et al.
Plos One
|
June 4, 2016
Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein
Zhifeng Chen, Lan Zhang, Aimin Tang, et al.
Vaccine: X
|
August 7, 2019
Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment
Brian K Meyer, Mark A F Kendall, Donna M Williams, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 25, 2003
Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates
Stefania Lamartina, Luisa Silvi, Giuseppe Roscilli, et al.
Vaccine
|
March 13, 2012
An optimized SIV DNA vaccine can serve as a boost for Ad5 and provide partial protection from a high-dose SIVmac251 challenge
Natalie A Hutnick, Devin J F Myles, Lauren Hirao, et al.
Page
of 3